Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Morning Bell 21 March

Sophia Mavridis
March 21, 2022

Weekly Wrap 18 March

Sophia Mavridis
March 18, 2022

Morning Bell 17 March

Paulina Peters
March 17, 2022

Morning Bell 16 March

Sophia Mavridis
March 16, 2022

Morning Bell 15 March

Paulina Peters
March 15, 2022

Morning Bell 14 March

Sophia Mavridis
March 14, 2022

Weekly Wrap 11 March

Sophia Mavridis
March 11, 2022

Morning Bell 10 March

Sophia Mavridis
March 10, 2022

Morning Bell 9 March

Paulina Peters
March 9, 2022

Morning Bell 8 March

Sophia Mavridis
March 8, 2022

Morning Bell 7 March

Sophia Mavridis
March 7, 2022

Weekly Wrap 4 March

Sophia Mavridis
March 4, 2022